Avro­bio ends all de­vel­op­ment, search­es for life af­ter re­cent gene ther­a­py sale to No­var­tis

Gene ther­a­py mak­er Avro­bio has flashed the red lights on all de­vel­op­ment and is now eval­u­at­ing its fu­ture, join­ing a grow­ing list of biotechs to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.